Form 4: Accenture Director Receives Future RSU Grant

Accenture plc Director Paula A. Price is set to receive a grant of 7 Class A ordinary shares as Restricted Share Units on November 14, 2025, under anti-dilution provisions.

Summary

• Paula A. Price, a Director of Accenture plc, will acquire 7 Class A ordinary shares.
• The acquisition is scheduled to occur on November 14, 2025.
• These shares are granted as Restricted Share Units (RSUs) at a price of $0.
• The grant is made pursuant to anti-dilution provisions of previously awarded RSU awards, reflecting Accenture plc's payment of a cash dividend.
• Following this transaction, Paula A. Price will beneficially own 7,368 Class A ordinary shares directly.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating it was pre-planned.

Sentiment

Score: 5

Explanation: This is a routine, expected transaction related to executive compensation and anti-dilution, not indicating significant positive or negative news for the company's operations or financial health.

Positives

• Director Paula A. Price will receive additional equity in Accenture plc, further aligning her interests with shareholders.
• The grant ensures that previously awarded Restricted Share Units maintain their value against dilution from cash dividends, protecting the value of existing equity compensation.

Future Outlook

N/A

Industry Context

This is a routine insider transaction related to executive compensation, common across publicly traded companies, and does not reflect broader industry trends.

Comparison to Industry Standards

• The grant of Restricted Share Units with anti-dilution provisions is a standard practice in executive compensation across major corporations, including peers in the consulting and technology services sector like Deloitte, EY, and PwC, ensuring equity awards maintain value post-dividend.

Stakeholder Impact

• Shareholders: Minor dilution from the issuance of 7 shares, but reflects standard compensation practices.
• Management/Directors: Paula A. Price's equity stake in the company will increase, further aligning her interests with shareholders.

Key Dates

Recommendation

This Form 4 reports a routine, pre-scheduled grant of 7 Restricted Share Units to a director as part of an anti-dilution adjustment. Such a minor, expected transaction has no material impact on the company's fundamentals or valuation and therefore does not warrant a change in investment recommendation.

Keywords

Accenture, ACN, Form 4, insider transaction, director, RSU, restricted stock units, equity grant, anti-dilution, dividend, 10b5-1 plan